|1.||Dodo, Kosuke: 2 articles (05/2015 - 10/2008)|
|2.||Misawa, Takashi: 2 articles (05/2015 - 10/2008)|
|3.||Kizaki, Masahiro: 2 articles (05/2015 - 10/2008)|
|4.||Hashimoto, Yuichi: 2 articles (05/2015 - 10/2008)|
|5.||Sagawa, Morihiko: 2 articles (05/2015 - 10/2008)|
|6.||Aoyama, Hiroshi: 2 articles (05/2015 - 10/2008)|
|7.||Ishikawa, Minoru: 1 article (05/2015)|
|8.||Miyachi, Hiroyuki: 1 article (10/2008)|
|9.||Furuyama, Taniyuki: 1 article (10/2008)|
|1.||Venous Thrombosis (Deep-Vein Thrombosis)
04/02/1993 - "Studies on structure-activity relationships revealed that compounds having an electron-withdrawing group in the benzhydril or benzhydrol moiety, and specifically those having the beta-D-xylopyranosyl structure in the sugar moiety, were good antithrombotic agents in a rat model of venous thrombosis."
|2.||Schizophrenia (Dementia Praecox)
05/01/2015 - "We herein examined the structure-activity relationships of ACA derivatives based on the benzhydrol skeleton in human leukemia cells (HL-60). "
10/01/2008 - "Benzhydrol-type analogs of 1'-acetoxychavicol acetate (ACA) were developed as inhibitors of human leukemia HL-60 cell growth based on quantitative structure-activity relationship (QSAR) analysis. "
10/01/2008 - "Structural development of benzhydrol-type 1'-acetoxychavicol acetate (ACA) analogs as human leukemia cell-growth inhibitors based on quantitative structure-activity relationship (QSAR) analysis."
|1.||Fibrinolytic Agents (Antithrombotic Agents)